cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Alloxan Diabetes

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, ZY; Lee, YL; Park, HJ; Park, HS; Park, YD; Yoon, HS	1

Other Studies

1 other study(ies) available for cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Alloxan Diabetes

Article	Year
Endogenous somatostatin inhibits interaction of insulin and cholecystokinin on exocrine secretion of isolated, perfused rat pancreas. Pancreas, 2002, Volume: 24, Issue:4 Topics: Animals; Cholecystokinin; Diabetes Mellitus, Experimental; Drug Interactions; Glucose; Hormone Antagonists; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Pancreas; Perfusion; Rats; Rats, Sprague-Dawley; Somatostatin	2002

Article

Year

Endogenous somatostatin inhibits interaction of insulin and cholecystokinin on exocrine secretion of isolated, perfused rat pancreas.

Pancreas, 2002, Volume: 24, Issue:4

Topics: Animals; Cholecystokinin; Diabetes Mellitus, Experimental; Drug Interactions; Glucose; Hormone Antagonists; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Pancreas; Perfusion; Rats; Rats, Sprague-Dawley; Somatostatin

2002